| Literature DB >> 28775767 |
C J Nester1, A Graham1, A Martinez-Santos1, A E Williams1, J McAdam1, V Newton1.
Abstract
BACKGROUND: Foot orthoses have been advocated in the management of a wide range of clinical foot and lower limb problems and are within the scope of podiatry, orthotic and physiotherapy practice. Previous reports into the provision of orthoses have consistently identified significant issues with services and devices, but data were never specific to foot orthoses. The aim of this first of a series of papers was to report the first ever national multi professional profile of foot orthosis provision in the United Kingdom.Entities:
Mesh:
Year: 2017 PMID: 28775767 PMCID: PMC5540424 DOI: 10.1186/s13047-017-0215-4
Source DB: PubMed Journal: J Foot Ankle Res ISSN: 1757-1146 Impact factor: 2.303
Fig. 1% of responders in each profession and their gender, age and location
% of responders indicating type of service in which they work, patient groups treated, patient groups receiving prescription footwear and training undertaken since qualifying
| Type of service | Patient group | Patient group receiving prescription footwear | Additional training undertaking since qualifying |
|---|---|---|---|
| 61.1% podiatry | 90.4% MSK | 21.4% diabetes | 80% lower limb biomechanics |
| 31.1% MSK | 72.1% OA | 17.6% arthritis | 60.1% gait analysis |
| 23.8% orthotics | 63.7% sport | 17.4% other high-risk | 57.5% orthoses prescription |
| 10.2% physiotherapy | 63.3% diabetes | 15.8% OA | 42.3% sports injuries |
| 8.2% surgery | 59.1% arthritis | 14.6% MSK | 31.5% podopaediatrics |
| 5.2% rheumatology | 50.5% paediatrics | 12.4% neuro adult | 30.7% orthopaedics |
| 3.2% CATS | 45.5% adult neurology | 10.2% neuro paediatrics | 29.7% specialist footwear |
| 2.4% diabetes | 39.7% other high risk (e.g. stroke patients) | 9.0% general paediatrics | 26.7% steroid injection therapy |
| 2.4% other | 33.3% falls prevention | 8.4% falls | 26.3% manipulation |
| 3.6% “other” including post-surgery | 21.0% neurology | ||
| 18.0% strength and conditioning training | |||
| 7.6% no training | |||
| 3.4% alternative therapies | |||
| 2.8% high risk population | |||
| 2.4% surgery | |||
| 1.2% diagnosis techniques | |||
| 2.2% other training |
CATS Clinical Assessment and Treatment Service, MSK Musculoskeletal, OA osteoarthritis
Percent of week spent providing orthoses, time available for assessing patients, the number of orthoses provided per month, provision of second pair of orthoses, patients with prior use of orthoses, and clinician and patient objectives. All data are % all responders
| % of week spent providing orthoses | Duration of assessment appointment | Number of orthoses per month and second pairs | Patient with prior orthoses | Clinician objectives | Patient objectives |
|---|---|---|---|---|---|
| 39.5% <10% of week | 35.9% = 30–45 mins | 44.5% = 11–50 pairs | 55.5% = 0–25% of patients | 85.8% pain relief | 68.3% pain reduction |
| 37.5% = 11–50% | 31.3% = 15–30 mins | 36.1% = 1–10 pairs | 29.3% =26–50% | 66.9% functional control | 63.1% return to sport level |
| 20.6% = 51–90% | 22.8% = 45–60 mins | 14.0% = 51–100 pairs | 8.0% = 51–75% | 46.1% pressure relief | 48.9% pain remission |
| 2.4% = 100% | 4.4% > 60 mins | 5.4% = 100+ pairs | 1.6% = 76–100% | 22.8% rehabilitation (>6 months) | 37.3% return to exercise |
| 4.2% < 15 mins |
| 5.6% = did not know | 21.2% accommodation of deformity | 31.1% injury prevention | |
|
| 19.4% ulcer prevention | 9.2% return to work | |||
|
| 16.2% rehabilitation (<6 months) | 6.4% return to preferred footwear | |||
|
| 14.6% stability | 4.8% fall prevention | |||
|
| 18.0% did not know |
% of responders using each material for prefabricated orthoses, modifying prefabricated orthoses, the number of prefabricated orthoses from which responders choose, and satisfaction with choices of prefabricated orthoses
| Prefabricated orthoses | |||
|---|---|---|---|
| Material | Modified | Range | Choice |
| 77.8% medium density EVA | 34.4% modified 51–80% | 35.7% choice of 2–5 orthoses | 77.4% satisfied with range |
| 52.1% rigid plastics | 27.5% modified 11–50% | 32.5% choice of > 10 | 13.8% not satisfied |
| 46.9% high density EVA | 10.8% modified 81–90% | 17.6% choice of 5–10. | 8.8% did not answer |
| 38.3% low density EVA | 10.4% modified 1–10% | 2.4% had 1 design to use | 68.7% of the responders had influence over the range available. |
| 11.2% carbon fibre | 5.8% modified all | ||
| 3.2% cushioning’ orthoses | 3.2% never modified | ||
| 6.8% did not answer | |||
EVA ethylene vinyl acetate
% of responders using each material for customised orthoses, modifying customised orthoses, using each method of capturing foot shape and using each method of manufacture
| Customised orthoses | |||
|---|---|---|---|
| Material | Modified | Shape capture | Manufacture method |
| 62.3% medium density EVA | 40.9% modified ≤20% | 54.1% foam boxes | 29.1% handmade |
| 51.7% rigid plastics | 19.4% modified 21–99% | 39.9% plaster cast | 28.7% CAD/CAM |
| 43.1% high density EVA | 2.6% modified all | 14.2% scanner | 5.4% did not know |
| 28.1% low density EVA | 11.4% never modified (25.7% did not answer). | 9.8% direct measures | 4.6% mix of both approaches |
| 25.5% carbon fibre | 3.0% did not take foot impressions. | 27.1% did not answer. | |
| (<3.0%, used polyurethane, cushioning, and 3D printed orthoses) | |||
CAD/CAM computer aided design/computer aided manufacture, EVA ethylene vinyl acetate